INR 244.2
(-0.61%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 408.15 Million | 693.29 Million | 726.79 Million | 648.26 Million | 563.41 Million | 856.04 Million |
Net Income | 220.02 Million | 373.61 Million | 503.86 Million | 223.38 Million | 35.84 Million | 255.77 Million |
Depreciation & Amortization | 297.09 Million | 286.02 Million | 300.11 Million | 295.14 Million | 299.67 Million | 214.28 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -104.93 Million | 69.08 Million | -31.13 Million | 43.08 Million | 5.85 Million | 248.38 Million |
Other non-cash items | 672.69 Million | -35.43 Million | -46.05 Million | 86.65 Million | 222.02 Million | 137.59 Million |
Investing Cash Flow | -483.56 Million | -159.21 Million | -59.09 Million | -89.4 Million | -246.43 Million | -844.35 Million |
Investments in PPE | -513.46 Million | -186.7 Million | -191.1 Million | -172.7 Million | -259.86 Million | -848.19 Million |
Acquisitions | 41.18 Million | 22.98 Million | 130.56 Million | 78.23 Million | 2.59 Million | 2.06 Million |
Investment purchases | -11.4 Million | - | -71 Thousand | -77 Thousand | 3.01 Million | - |
Sales/Maturities of investments | 110 Thousand | 1.93 Million | 1.00 | 2.76 Million | 5.04 Million | - |
Other Investing Activities | -11.4 Million | 2.57 Million | 1.51 Million | 2.37 Million | 2.78 Million | 1.78 Million |
Financing Cash Flow | 58.3 Million | -543.26 Million | -650.57 Million | -522.43 Million | -310.96 Million | -61.14 Million |
Debt repayment | -98.22 Million | -307.98 Million | -292.5 Million | -162.5 Million | -100 Million | -100.44 Million |
Dividends payments | -17.34 Million | -17.59 Million | -24.2 Million | -32.59 Million | -42.89 Million | -47.83 Million |
Common Stock Repurchased | - | - | -74.52 Million | -149.04 Million | - | -39.45 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 161.46 Million | -217.68 Million | -259.34 Million | -178.28 Million | -168.06 Million | 126.58 Million |
Accounts receivables | -56.79 Million | 75.87 Million | 3.51 Million | -6.15 Million | 113.12 Million | 188.7 Million |
Accounts payables | 20.12 Million | -24.93 Million | 9.93 Million | 19.71 Million | 7.13 Million | -50.83 Million |
Inventory | -45.85 Million | 61.07 Million | -48.84 Million | -38.83 Million | 50.96 Million | -24.75 Million |
Other working capital | -22.4 Million | -42.92 Million | 4.26 Million | 68.35 Million | -165.36 Million | 135.27 Million |
Cash at beginning of period | 24.91 Million | 2.32 Million | -14.79 Million | -51.22 Million | -57.24 Million | -7.79 Million |
Cash at end of period | 8.24 Million | -6.86 Million | 2.32 Million | -14.79 Million | -51.22 Million | -57.24 Million |
Capital Expenditure | -513.46 Million | -186.7 Million | -191.1 Million | -172.7 Million | -259.86 Million | -848.19 Million |
Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
Net cash flow / Change in cash | -16.67 Million | -9.18 Million | 17.12 Million | 36.43 Million | 6.01 Million | -49.45 Million |
Free Cash Flow | -105.31 Million | 506.58 Million | 535.69 Million | 475.56 Million | 303.54 Million | 7.84 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 38.85 Million | 66.39 Million | 220.02 Million | 25.29 Million | 51.51 Million | 76.81 Million |
Depreciation & Amortization | - | - | 297.09 Million | 75.2 Million | 72.19 Million | 69.28 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -104.93 Million | - | - | - |
Other non-cash items | -38.85 Million | -66.39 Million | 672.69 Million | -25.29 Million | -51.51 Million | -76.81 Million |
Investing Cash Flow | - | - | -483.56 Million | - | - | - |
Investments in PPE | - | - | -513.46 Million | - | - | - |
Acquisitions | - | - | 41.18 Million | - | - | - |
Investment purchases | - | - | -11.4 Million | - | - | - |
Sales/Maturities of investments | - | - | 110 Thousand | - | - | - |
Other Investing Activities | - | - | -11.4 Million | - | - | - |
Financing Cash Flow | - | - | 58.3 Million | - | - | - |
Debt repayment | - | - | -98.22 Million | - | - | - |
Dividends payments | - | - | -17.34 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 161.46 Million | - | - | - |
Accounts receivables | - | - | -56.79 Million | - | - | - |
Accounts payables | - | - | 20.12 Million | - | - | - |
Inventory | - | - | -45.85 Million | - | - | - |
Other working capital | - | - | -22.4 Million | - | - | - |
Cash at beginning of period | - | - | 24.91 Million | 12.87 Million | -38.64 Million | 24.91 Million |
Cash at end of period | - | - | 8.24 Million | 25.29 Million | 12.87 Million | 76.81 Million |
Capital Expenditure | - | - | -513.46 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -16.67 Million | 12.42 Million | 51.51 Million | 51.89 Million |
Free Cash Flow | - | - | -105.31 Million | 25.29 Million | 51.51 Million | 76.81 Million |
CEEB3
JYOTIRES
JFWV
INSECTICID
TCNT
RCI-A